TAMPA, Fla., Nov. 7, 2015/PRNewswire / -- CareFusion, a BD company (NYSE:BDX), was presented today with the Zenith Award for the second year in a row from the American Association for Respiratory Care (AARC) at the 61st International Respiratory Congress and Exhibition being held today through Nov. 10in Tampa, Fla.

Voted on by AARC members, the Zenith Award is given to the top corporations in the respiratory care industry and is widely considered the 'people's choice' award of the respiratory care profession. Members are asked to evaluate companies that have the most outstanding: Quality of equipment and supplies; Accessibility and helpfulness of sales personnel; Responsiveness; Service record; Truth in advertising; and Support of the respiratory care profession. This marks the eighth time that CareFusion has received this award.

'We have been dedicated to the respiratory care profession since 1955 when Dr. Forrest Birddeveloped the first mechanical ventilator, and we strive to continue his tradition of innovation, quality, support and service to the respiratory care community,' said Ruth Lundstrom, vice president and general manager of Ventilation at CareFusion. 'On behalf of more than 100 respiratory care professionals at CareFusion that support our customers and their patients, it is an honor to receive the Zenith award and serve this profession.'

CareFusion is highlighting its respiratory solutions in booth 401 at the AARC Congress including ventilators, respiratory diagnostics and AirLife® respiratory products.

About CareFusion
CareFusion, a BD company, serves the health care industry with products and services that help hospitals measurably improve the safety and quality of care. The company develops industry-leading technologies including Alaris® infusion pumps and IV sets, MaxPlus® and MaxZero™ IV connectors and sets, Pyxis® automated dispensing and patient identification systems, AVEA®, LTV® series and AirLife® ventilation and respiratory products, ChloraPrep® products, MedMined® services for data mining surveillance, V. Mueller® surgical instruments, and an extensive line of products that support interventional medicine. For more information please visit www.carefusion.com.

About BD
 BD is a leading medical technology company that partners with customers and stakeholders to address many of the world's most pressing and evolving health needs. Our innovative solutions are focused on improving medication management and patient safety; supporting infection prevention practices; equipping surgical and interventional procedures; improving drug delivery; aiding anesthesiology and respiratory care; advancing cellular research and applications; enhancing the diagnosis of infectious diseases and cancers; and supporting the management of diabetes. We are more than 45,000 associates in 50 countries who strive to fulfill our purpose of 'Helping all people live healthy lives' by advancing the quality, accessibility, safety and affordability of healthcare around the world. In 2015, BD welcomed CareFusion and its products into the BD family of solutions. For more information on BD, please visit www.bd.com.

SOURCE CareFusion

For further information: Media: Troy Kirkpatrick, (858) 617-2361, troy.kirkpatrick@carefusion.com; or Investors: Monique N. Dolecki, (201) 847-5378, monique_dolecki@bd.com

distributed by